Sodium (4-Chloro-3-Methylisoxazol-5-Yl)((2-(2-(6-Methylbenzo[D][1,3]Dioxol-5-Yl)Acetyl)Thiophen-3-Yl)Sulfonyl)Amide (4-氯-3-甲基异恶唑-5-基)((2-(2-(6-甲基苯并[d][1,3]二氧杂戊环-5-基)乙酰基)噻吩-3-基)磺酰基)胺钠盐
CAS 210421-74-2 MFCD11040990
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Heterocycles
- Pharmaceuticals
- Intermediates & Fine Chemicals
- Sulfur & Selenium Compounds
产品应用
- Selective endothelin A (ETA) receptor antagonist. Antihypertensive. Used in treatment of chronic heart failure.
相关文献及参考
- [2]. Tilton RG, et al. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist. Pulm Pharmacol Ther. 2000;13(2):87-97.
- [3]. Rondelet B, et al. Sildenafil added to sitaxsentan in overcirculation-induced pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1118-23. Epub 2010 Aug 6.
- Horn, E.M., et al.: Expert. Opin. Invest. Drugs, 13, 1483 (2004),
- Tilton, R.G., et al.: Pulm. Pharmacol. Ther., 13, 87 (2000),
- Wu, C., et al.: J. Med. Chem., 40, 1690 (1997),
- [1]. Hartman JC, et al. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and si
- [1]. Hartman JC, et al. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes. Can J Physiol Pharmacol. 2010 Jun;88